Oncopeptides AB (ONPPF)
0.265
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Oncopeptides Price to Book Value: 1.961 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.961 |
| May 15, 2024 | 1.961 |
| May 14, 2024 | 1.961 |
| May 13, 2024 | 1.961 |
| May 10, 2024 | 1.961 |
| May 09, 2024 | 1.961 |
| May 08, 2024 | 1.961 |
| May 07, 2024 | 1.961 |
| May 06, 2024 | 1.961 |
| May 03, 2024 | 1.961 |
| May 02, 2024 | 2.915 |
| May 01, 2024 | 2.915 |
| April 30, 2024 | 2.915 |
| April 29, 2024 | 2.915 |
| April 26, 2024 | 2.915 |
| April 25, 2024 | 2.915 |
| April 24, 2024 | 2.915 |
| April 23, 2024 | 2.915 |
| April 22, 2024 | 2.915 |
| April 19, 2024 | 2.915 |
| April 18, 2024 | 2.915 |
| April 17, 2024 | 2.915 |
| April 16, 2024 | 2.915 |
| April 15, 2024 | 4.440 |
| April 12, 2024 | 4.440 |
| Date | Value |
|---|---|
| April 11, 2024 | 4.440 |
| April 10, 2024 | 4.440 |
| April 09, 2024 | 4.440 |
| April 08, 2024 | 4.440 |
| April 05, 2024 | 4.440 |
| April 04, 2024 | 4.440 |
| April 03, 2024 | 4.440 |
| April 02, 2024 | 4.440 |
| April 01, 2024 | 4.440 |
| March 28, 2024 | 4.440 |
| March 27, 2024 | 4.440 |
| March 26, 2024 | 4.440 |
| March 25, 2024 | 4.440 |
| March 22, 2024 | 4.440 |
| March 21, 2024 | 4.440 |
| March 20, 2024 | 4.440 |
| March 19, 2024 | 4.440 |
| March 18, 2024 | 4.440 |
| March 15, 2024 | 4.440 |
| March 14, 2024 | 4.440 |
| March 13, 2024 | 4.440 |
| March 12, 2024 | 4.440 |
| March 11, 2024 | 4.440 |
| March 08, 2024 | 4.440 |
| March 07, 2024 | 4.440 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.961
Minimum
May 03 2024
21.00
Maximum
Jun 29 2021
4.233
Average
4.379
Median
May 13 2022
Price to Book Value Benchmarks
| Abliva AB | 1.914 |
| Karolinska Development AB | 0.5938 |
| Calliditas Therapeutics AB | 17.78 |
| Olink Holding AB | 6.451 |
| BioInvent International AB | 2.673 |
Price to Book Value Related Metrics
| PS Ratio | 8.280 |
| Price | 0.265 |
| Earnings Yield | -102.3% |
| Market Cap | 23.97M |